Literature DB >> 19925886

Peripheral Th-17 cells in allergic rhinitis: New evidence.

Giorgio Ciprandi1, Gilberto Filaci, Florinda Battaglia, Daniela Fenoglio.   

Abstract

BACKGROUND: Th17 is a subset of T helper lymphocytes exerting inflammatory activities. Recently, it has been reported that serum IL-17 levels are high in patients with severe birch allergy. AIM OF THE STUDY: It was to compare the cytokine profile and the frequency of peripheral allergen-specific T helper producing IL-17 in patients with allergic rhinitis.
METHODS: Twelve patients with persistent allergic rhinitis due to pollens and 5 healthy non-allergic subjects were evaluated during the pollen season. Th17 were evaluated by intracellular staining in T cell compartment ex-vivo and after short activation by allergens and control antigens.
RESULTS: Ex-vivo PBMNC evaluation showed that allergic patients had higher frequencies of IL-17 producing T cells. Functional analysis after antigen-specific CD4+ T cell expansion demonstrated that allergic patients had higher frequencies of IL-17 producing T cells than normal subjects.
CONCLUSION: This preliminary study contributes to the knowledge concerning the possible role of Th-17 cells in the response to allergens. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925886     DOI: 10.1016/j.intimp.2009.11.004

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

Review 1.  The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases.

Authors:  Giuseppe Murdaca; Barbara Maria Colombo; Francesco Puppo
Journal:  Intern Emerg Med       Date:  2011-01-22       Impact factor: 3.397

Review 2.  The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma.

Authors:  Yves Laumonnier; Inken Schmudde; Jörg Köhl
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

3.  Response of peripheral blood Th17 cells to inhaled Dermatophagoides pteronyssinus in patients with allergic rhinitis and asthma.

Authors:  Ieva Bajoriuniene; Kestutis Malakauskas; Simona Lavinskiene; Jolanta Jeroch; Edita Gasiuniene; Astra Vitkauskiene; Raimundas Sakalauskas
Journal:  Lung       Date:  2012-07-28       Impact factor: 2.584

4.  Mitochondrial ROS activate interleukin-1β expression in allergic rhinitis.

Authors:  Qiping Shi; Zhiwei Lei; Gui Cheng; Dehai Li; Qian Wang; Simin Luo; Hengwen Yang; Haiying Jia
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

5.  Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3.

Authors:  Jonathan P Huber; Hilario J Ramos; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Update in the mechanisms of allergen-specific immunotheraphy.

Authors:  Tunc Akkoc; Mübeccel Akdis; Cezmi A Akdis
Journal:  Allergy Asthma Immunol Res       Date:  2010-11-16       Impact factor: 5.764

7.  Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.

Authors:  Luis Diego Archila; David Jeong; Mariona Pascal; Joan Bartra; Manel Juan; David Robinson; Mary L Farrington; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2015-03-13       Impact factor: 10.793

8.  Local expression of interleukin-17a is correlated with nasal eosinophilia and clinical severity in allergic rhinitis.

Authors:  Seiichiro Makihara; Mitsuhiro Okano; Tazuko Fujiwara; Yohei Noda; Takaya Higaki; Tomomi Miyateke; Kengo Kanai; Takenori Haruna; Shin Kariya; Kazunori Nishizaki
Journal:  Allergy Rhinol (Providence)       Date:  2014-04-22

9.  Evaluating the immune responses of mice to subcutaneous immunization with Helicobacter pylori urease B subunit.

Authors:  Peng Sun; Jia-Qi Wang; Yu-Tao Zhang; Sheng-Guo Zhao
Journal:  J Anim Sci Biotechnol       Date:  2014-02-22

10.  In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients.

Authors:  Chun Wei Li; Han Gui Lu; De Hua Chen; Zhi Bin Lin; De Yun Wang; Tian Ying Li
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.